Join our Mailing List
We create customized solutions to help you achieve your development goals, reduce costs and accelerate time-to-market
Pii is a leading provider of dosage form development and cGMP manufacturing services to the global pharmaceutical industry. Pii develops and manufactures a wide range of dosage forms covering solid, semi-solid, liquid, inhalation and parenteral.
Comprehensive offerings include API characterization and solid state screening, preformulation testing, dosage form development, CTM manufacturing and commercial manufacturing. These services are complemented by full analytical, regulatory and project management support.
With more than 400 development programs under our belt, Pii’s highly trained scientific team has extensive experience working with a variety of drug substances having a range of physicochemical characteristics. For poorly soluble compounds, Pii offers multiple bioavailability enhancement technologies, including solid dispersion development, particle size reduction, and solubilization technologies. Additionally, Pii’s development expertise includes immediate, modified and sustained release formulations. Each formulation is designed around the molecule’s physicochemical properties and the dosage form desired.
Services Offered Include: